Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
26 Apr 24
ARS
2023 FY
Annual report to shareholders
26 Apr 24
8-K
Exagen Inc. Announces Changes to the Board of Directors
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
10-K
2023 FY
Annual report
18 Mar 24
8-K
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
18 Mar 24
8-K
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
8 Jan 24
8-K
Departure of Directors or Certain Officers
11 Dec 23
EFFECT
Notice of effectiveness
30 Nov 23
424B5
Prospectus supplement for primary offering
29 Nov 23
CORRESP
Correspondence with SEC
28 Nov 23
S-3/A
Shelf registration (amended)
27 Nov 23
UPLOAD
Letter from SEC
22 Nov 23
424B5
Prospectus supplement for primary offering
20 Nov 23
8-K
Entry into a Material Definitive Agreement
17 Nov 23
S-3
Shelf registration
17 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Exagen Inc. Reports Strong Third Quarter 2023 Results
13 Nov 23
8-K
Entry into a Material Definitive Agreement
26 Oct 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
8-K
Exagen Inc. Reports Strong Second Quarter 2023 Results
7 Aug 23
8-K
Exagen Inc. Appoints Paul Kim to Board of Directors
24 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 23
DEFA14A
Additional proxy soliciting materials
24 May 23
S-8
Registration of securities for employees
18 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Exagen Inc. Reports First Quarter 2023 Results
15 May 23
8-K
Entry into a Material Definitive Agreement
4 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
8-K
Departure of Directors or Certain Officers
23 Mar 23
10-K
2022 FY
Annual report
20 Mar 23
8-K
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
20 Mar 23
8-K
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
23 Jan 23
8-K
Results of Operations and Financial Condition
9 Jan 23
8-K
Cost Associated with Exit or Disposal Activities
5 Dec 22
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
Latest ownership filings
4
Kamal Adawi
6 Mar 24
4
JOHN ABALLI
4 Mar 24
4
Kamal Adawi
22 Feb 24
4
JOHN ABALLI
22 Feb 24
SC 13G/A
LYTTON LAURENCE W
14 Feb 24
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 24
SC 13G/A
Stonepine Capital Management, LLC
13 Feb 24
SC 13G/A
TULLIS DICKERSON CAPITAL FOCUS III, L.P.
13 Feb 24
SC 13G/A
WASATCH ADVISORS LP
9 Feb 24
4
Kamal Adawi
8 Feb 24
SC 13G/A
Cowen Financial Products LLC
2 Feb 24
SC 13G/A
NMSIC Co-Investment Fund, L.P.
22 Jan 24
4
JOHN ABALLI
18 Oct 23
4
JOHN ABALLI
6 Sep 23
4
Paul Kim
26 Jul 23
3
Paul Kim
26 Jul 23
4
JAMES L L TULLIS
20 Jun 23
4
Tina Susan Nova
20 Jun 23
4
Frank Stokes
13 Jun 23
4
Brian Birk
13 Jun 23
4
EBETUEL PALLARES
13 Jun 23
4
Ana Hooker
13 Jun 23
4
Wendy S. Johnson
13 Jun 23
4
Kamal Adawi
3 Mar 23
4
Mark Hazeltine
3 Mar 23
4
Kamal Adawi
1 Mar 23
4
Mark Hazeltine
1 Mar 23
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 23
SC 13G/A
LYTTON LAURENCE W
13 Feb 23
SC 13G/A
Stonepine Capital Management, LLC
13 Feb 23
4
Mark Hazeltine
10 Feb 23
4
Kamal Adawi
10 Feb 23
SC 13G/A
WASATCH ADVISORS INC
9 Feb 23
SC 13G/A
TULLIS DICKERSON CAPITAL FOCUS III, L.P.
7 Feb 23
SC 13G/A
BANK OF MONTREAL /CAN/
6 Feb 23
SC 13G/A
NMSIC Co-Investment Fund, L.P.
2 Feb 23
SC 13G/A
Cowen Financial Products LLC
23 Jan 23
4
JOHN ABALLI
9 Dec 22
SC 13G
LYTTON LAURENCE W
23 Nov 22
4
JOHN ABALLI
18 Oct 22